F.A. KHABIROV^1, 2, T.I. KHAYBULLIN^1, 2, E.V. GRANATOV², L.A. AVERIANOVA², N.N. BABICHEVA², ZH.F. SABIROV², V.A. SHIKHOVA², M.A. YAKUPOV²

 ¹Kazan State Medical Academy, Kazan

²Republican Clinical Neurological Centre, Kazan

Contact details:

Khabirov F.A. — Doctor of science, Professor, Head of the Neurology Department, Chief physician

Address: 13 Vatutin St., Russian Federation, Kazan, 420021, tel.: +7 (843) 278-23-17, e-mail: [email protected]

 The purpose — to clarify the clinical and epidemiological characteristics of multiple sclerosis (MS) in the Republic of Tatarstan (RT).

Material and methods. A retrospective analysis of the register of MS patients in RT from 2015 to 2019 was carried out. The sample size was 2351 patients. The type of MS course, disease duration, clinical characteristics, including EDSS and MSSS scores, used by disease modifying therapies (DMT) were analyzed.

Results and conclusions. The prevalence of MS in RT continues to grow and has increased by 29% over a 5-year period (from 46,6 to 60,3 per 100,000 population in 2015 and 2019, respectively). The incidence has relatively stabilized and averages 4,2 cases per 100,000 population per year. The dominant type of MS course in RT is remitting (51,3%), patients with progressive forms account for 48,7%, including those with primary progressive MS (6,9%). In RT, a positive tendency towards a more favorable course of the disease with a decrease in the degree of patients’ disability was traced, mainly due to early diagnosis and timely prescription of adequate treatment with DMT. The problem of timely diagnosis of MS in children and adolescents and in the primary progressive course of MS remains.

Key words: multiple sclerosis, epidemiology, incidence, prevalence, Tatarstan Republic.

REFERENCES

1. Boyko A.N., Khabirov F.A., Khaybullin T.I. Rasseyannyy skleroz: kratkoe rukovodstvo dlya prakticheskogo vracha. 4-e izd. ispr. i dop. [Multiple Sclerosis: A Brief Guide for the Practitioner. 4th ed. rev. and add.]. Kazan: ID «MeDDoK», 2020. 116 p.
2. Kotov S.V., Yakushina T.I., Lizhdvoy V.Yu. Clinical and epidemiological aspects of multiple sclerosis in the Moscow region. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2012, vol. 112, pp. 60–62 (in Russ.).
3. Howard J., Trevick S., Younger D.S. Epidemiology of Multiple Sclerosis. Neurol. Clin, 2016, vol. 34 (4), pp. 919–939. DOI: 10.1016/j.ncl.2016.06.016
4. Leray E., Moreau T., Fromont A., Edan G. Epidemiology of multiple sclerosis. Rev. Neurol. (Paris), 2016, vol. 172 (1), pp. 3–13. DOI: 10.1016/j.neurol.2015.10.006
5. Ochi H. Epidemiology of Multiple Sclerosis: Is Multiple Sclerosis on the Rise? Brain Nerve, 2020, vol. 72 (5), pp. 467–484. DOI: 10.11477/mf.1416201551
6. Khabirov F.A., Babicheva N.N., Khaybullin T.I. Clinical and epidemiological characteristics of multiple sclerosis in the Republic of Tatarstan. Nevrologicheskiy vestnik. Zhurnal im. V.M. Bekhtereva, 2010, vol. 43, iss. 1, pp. 9–13 (in Russ.).
7. Khabirov F.A., Babicheva N.N., Esin R.G., Kochergina O.S., Granatov E.V., Khaybullin T.I. Clinical and socio-demographic characteristics of multiple sclerosis in the Republic of Tatarstan. Prakticheskaya meditsina, 2013, no. 1-1 (68), pp. 15–18 (in Russ.).
8. Babicheva N.N., Khabirov F.A., Granatov E.V., Khaybullin T.I., Aver’yanova L.A., Akhmedova G.M. Clinical and epidemiological characteristics of multiple sclerosis in the Republic of Tatarstan. Neyroimmunologiya. Nauchno-prakticheskaya konferentsiya nevrologov. XX Vserossiyskaya konferentsiya «Neyroimmunologiya. Rasseyannyy skleroz». III Simpozium «Sovremennye vozmozhnosti neyrovizualizatsii»: materialy, 2015. Vol. 12. No. 1–2. Pp. 15–16.
9. Roxburgh R.H., Seaman S.R., Masterman T., Hensiek A.E., Sawcer S.J., Vukusic S., Achiti I., Confavreux C., Coustans M., le Page E., Edan G., McDonnell G.V., Hawkins S., Trojano M., Liguori M., Cocco E., Marrosu M.G., Tesser F., Leone M.A., Weber A., Zipp F., Miterski B., Epplen J.T., Oturai A., Sørensen P.S., Celius E.G., Lara N.T., Montalban X., Villoslada P., Silva A.M., Marta M., Leite I., Dubois B., Rubio J., Butzkueven H., Kilpatrick T., Mycko M.P., Selmaj K.W., Rio M.E., Sá M., Salemi G., Savettieri G., Hillert J., Compston D.A. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology, 2005, vol. 64 (7), pp. 1144–1151. DOI: 10.1212/01.WNL.0000156155.19270.F8
10. Territorial’nyy organ Federal’noy sluzhby gosudarstvennoy statistiki po Respublike Tatarstan [Territorial body of the Federal State Statistics Service for the Republic of Tatarstan], available at: https://tatstat.gks.ru/
11. Ivanova E.V., Bakhtiyarova K.Z., Safronova E.V. Medical and social characteristics of patients with multiple sclerosis in Ufa. Mediko-sotsial’naya ekspertiza i reabilitatsiya, 2017, vol. 20 (4), pp. 181–184 (in Russ.). DOI: 10.18821/1560-9537-2017-20-4-181-184
12. Ivanova E.V., Bakhtiyarova K.Z. Assessment of economic damage from multiple sclerosis in the city of Ufa. Farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya, 2017, vol. 10 (3), pp. 22–27 (in Russ.). DOI: 10.17749/2070-4909.2017.10.3.022-027.